J. Lacy Sturdivant - Concepedia

Author

J. Lacy Sturdivant

Medical University of South Carolina ORCID

Also Known As

J L Sturdivant, J Lacy Sturdivant, J. L Sturdivant, J. L. Sturdivant, J. LACY STURDIVANT, J. Lacy Sturdivant, J. Sturdivant, J.L. Sturdivant, JOHN L. STURDIVANT, John L. Sturdivant

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Medical University of South Carolina Boston Scientific (United States)University of Alabama Northwestern University Genesis Medical Center

About

J. Lacy Sturdivant is an author at Medical University of South Carolina specializing in medicine, cardiac arrest, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	295
2	Public Health	2	2	81
3	Emergency Medicine	2	2	120
4	Biochemistry	1	1	52
5	Environmental Health	1	1	52

J. Lacy Sturdivant

Publications

Citations

H-Index

Page 1

	Year	Citations
Primary Results From the Understanding Outcomes With the S-ICD in Primary Prevention Patients With Low Ejection Fraction (UNTOUCHED) Trial Michael R. Gold, Pier D. Lambiase, Mikhael F. El‐Chami, Circulation	2020	211
Head‐To‐Head Comparison of Arrhythmia Discrimination Performance of Subcutaneous and Transvenous ICD Arrhythmia Detection Algorithms: The START Study Michael R. Gold, Dominic A.M.J. Theuns, Bradley P. Knight, Journal of Cardiovascular Electrophysiology	2011	209
A Prospective Comparison of AV Delay Programming Methods for Hemodynamic Optimization during Cardiac Resynchronization Therapy Michael R. Gold, Imran Khan Niazi, Michael Giudici, Journal of Cardiovascular Electrophysiology	2007	111
Implantable Cardioverter-Defibrillator Therapy for Primary Prevention of Sudden Death After Alcohol Septal Ablation of Hypertrophic Cardiomyopathy Frank Cuoco, William H. Spencer, Valerian Fernandes, Journal of the American College of Cardiology Primary PreventionAlcohol Septal AblationCardiomyopathyCardiogenic ShockCardiovascular Disease	2008	91
Safety of Continuous Anticoagulation With Dabigatran During Implantation of Cardiac Rhythm Devices C.P. Rowley, Michael L. Bernard, William W. Brabham, The American Journal of Cardiology ThrombosisCardiac AnaesthesiaDevice TherapyCardiovascular DiseaseCardiac Rhythm Devices	2013	60
Developmental toxicity assessment of the ionic liquid 1-butyl-3-methylimidazolium chloride in CD-1 mice Melissa M. Bailey, Megan B. Townsend, Peter L. Jernigan, Green Chemistry Cd-1 MiceComparative ToxicologyToxicological MechanismDevelopmental Toxicity AssessmentEnvironmental Health	2008	52
Comparison of the potential for developmental toxicity of prenatal exposure to two dietary chromium supplements, chromium picolinate and [Cr<sub>3</sub>O(O<sub>2</sub>CCH<sub>2</sub>CH<sub>3</sub>)<sub>6</sub>(H<sub>2</sub>O)<sub>3</sub>]<sup>+</sup>, in mice Melissa M. Bailey, J. Lacy Sturdivant, Peter L. Jernigan, Birth Defects Research Part B Developmental and Reproductive Toxicology	2007	43
The Effect of Left Ventricular Electrical Delay on the Acute Hemodynamic Response with Cardiac Resynchronization Therapy Michael R. Gold, Robert B. Leman, Nicholas Wold, Journal of Cardiovascular Electrophysiology	2014	40
Defibrillation Thresholds in Hypertrophic Cardiomyopathy Ernest Matthew Quin, Frank Cuoco, Matthew S. Forcina, Journal of Cardiovascular Electrophysiology	2010	38
Randomized comparison of defibrillation thresholds from the right ventricular apex and outflow tract Carl Reynolds, Vladimir P. Nikolski, J. Lacy Sturdivant, Heart Rhythm Randomized ComparisonDefibrillation ThresholdsHeart FailureCardiopulmonary ResuscitationElectrophysiological Evaluation	2010	29

Page 1